Conferences
#ESHCART2023

2nd How I Manage
CAR-T Therapies and Bispecific Antibodies for my Patients

‍

#ESHCART2023
Clinical Update
September 29-October 01, 2023
-
Berlin, Germany

Chairs: Ulrich Jäger, Marie José Kersten, Loretta Nastoupil

2nd How I Manage
CAR-T Therapies and Bispecific Antibodies for my Patients

‍

Information

‍

ABOUT THE CONFERENCE:

CAR-T cells and bispecific antibodies have advanced our therapeutic armamentarium for haematological malignancies. The programme of this ESH conference aims to provide an overview of the benefits and risks of currently available therapies for acute lymphoblastic leukaemia, lymphoma and multiple myeloma. Special focus will be placed on the advantages and disadvantages of bispecific antibodies vs. cellular therapies (including T cells, NK cells and transplant strategies). Future perspectives regarding applications in other haematological malignancies will also be discussed.

The format of the meeting is based on the analysis and discussion of clinical case studies. It will adopt a problem-solving approach, addressing practical considerations and guidelines. Emphasis will be placed on open discussion, ensuring a maximum level of interaction between faculty and registered participants. In addition to the scientific and medical issues addressed during the conference, the questions of affordability of and access to these novel expensive treatments will be tackled by medical experts, representatives of patient organisations, economists, regulatory authorities and industry.

‍

SCIENTIFIC TOPICS:

• Non-hodgkin lymphoma (NHL)
• Multiple myeloma
• Novel indications CAR T-cell therapy
• Managing toxicity of CAR-T and bispecific antibody treatment
• Real world data CAR-T
• Life after CAR T-cell therapy

‍

Programme

Read the final programme!

‍

CLICK HERE
ON-DEMAND CONTENT AVAILABLE
CLICK HERE

Corporate partners

With the support of*:

‍

‍

‍Major Conference Partner
*******

‍

‍

Level 2 Conference Partner
*******
‍

‍

‍Supporting Conference Partner
*******

‍

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

‍

Advancing haematology through international leading-edge disease- focused conferences.

Explore a portfolio of leading-edge scientific, translational research and clinically oriented meetings, designed to foster scientific exchange, practical insight, education and collaboration across clinical and research fields.
Explore all conferences